CorMedix, Inc. (CRMD)
11.72
+0.24
(+2.14%)
USD |
NASDAQ |
Dec 11, 16:00
11.72
0.00 (0.00%)
After-Hours: 18:34
CorMedix Cash from Investing (Quarterly): -291.32M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| ANI Pharmaceuticals, Inc. | -6.163M |
| Arcutis Biotherapeutics, Inc. | -25.25M |
| Alkermes Plc | -6.737M |
| Talphera, Inc. | -17.82M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 30.86M |
| Cash from Financing (Quarterly) | 150.53M |
| Free Cash Flow | 74.42M |
| Free Cash Flow Per Share (Quarterly) | 0.352 |
| Free Cash Flow to Equity (Quarterly) | 26.39M |
| Free Cash Flow to Firm (Quarterly) | 32.31M |
| Free Cash Flow Yield | 8.80% |